Medivant Healthcare (Tailstorm Health INC) is recalling approximately 27,560 syringes of Avastin (bevacizumab) 1.25mg/0.05mL sterile injection. The recall was initiated because the syringes lack sterility assurance, which means there is a risk that the product is contaminated with microorganisms. The affected product is repackaged into 0.5 mL single-dose syringes and distributed nationwide within the United States.
Injecting a product that lacks sterility assurance can lead to serious, potentially life-threatening infections at the site of injection or throughout the body. No specific injuries or infections have been reported to date for this recall.
Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.